p53, cancer and the immune response

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• The tumor suppressor p53, encoded by the TP53 gene, is critical for cancer-cell-autonomous functions.
• Emerging evidence highlights the significant impact of p53 status on the anti-tumor immune response.

Purpose of the Study:

• To elucidate the multifaceted role of p53 in both tumor cells and immune cells.
• To explore how p53 alterations in cancer influence immune cell dynamics and tumor progression.
• To identify therapeutic strategies leveraging the distinct p53 status between cancer and normal tissues.

Main Methods:

• Review of existing literature on p53 function in cancer and immunity.
• Analysis of studies investigating p53 mutations/loss in various cancer types.
• Examination of p53's effects on myeloid and T cell recruitment and activity.
• Investigation of p53's intrinsic functions within immune cells.

Main Results:

• Loss or mutation of p53 in cancer cells promotes immune evasion by affecting myeloid and T cell responses.
• Altered p53 status in tumors can lead to immune evasion and accelerated cancer progression.
• p53 also exerts functions within immune cells, influencing tumor development in diverse ways.
• Differential p53 status between tumor and normal cells presents therapeutic opportunities.

Conclusions:

• The p53 tumor suppressor plays a dual role in cancer, affecting both tumor cell behavior and the immune microenvironment.
• Understanding p53's complex interactions with immune cells is crucial for developing effective cancer immunotherapies.
• Targeting therapies based on the specific p53 status of a patient's cancer may enhance treatment efficacy.